If you have been prescribed Entyvio and get any side effects, talk to your doctor, pharmacist or nurse.
This includes any possible side effects not listed within this website or in the Patient Information Leaflet.
Adverse events should be reported. In the United Kingdom, reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to Takeda on 01628 537900 or e-mail DSO-UK@takeda.com
Entyvio® (vedolizumab) UK Website
Entyvio is a treatment for adults with moderately to severely active ulcerative colitis and moderately to severely active Crohn’s disease, two types of inflammatory bowel disease (IBD).
This website contains product and prescribing information intended for UK healthcare professionals. It also contains general information on IBD for the general public and resources on IBD and Entyvio for journalists and other media. Information for patients prescribed Entyvio is also included.